Does LUSPATERCEPT-AAMT Cause Off label use? 85 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Off label use have been filed in association with LUSPATERCEPT-AAMT. This represents 5.1% of all adverse event reports for LUSPATERCEPT-AAMT.
85
Reports of Off label use with LUSPATERCEPT-AAMT
5.1%
of all LUSPATERCEPT-AAMT reports
5
Deaths
20
Hospitalizations
How Dangerous Is Off label use From LUSPATERCEPT-AAMT?
Of the 85 reports, 5 (5.9%) resulted in death, 20 (23.5%) required hospitalization, and 2 (2.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUSPATERCEPT-AAMT. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does LUSPATERCEPT-AAMT Cause?
Death (162)
Haemoglobin decreased (98)
Fatigue (86)
Weight decreased (76)
Dizziness (64)
Product storage error (64)
Drug ineffective (58)
Dyspnoea (52)
Fall (51)
Weight increased (44)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LUSPATERCEPT-AAMT Alternatives Have Lower Off label use Risk?
LUSPATERCEPT-AAMT vs LUTEIN
LUSPATERCEPT-AAMT vs LUTETIUM LU-177
LUSPATERCEPT-AAMT vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
LUSPATERCEPT-AAMT vs LUTETIUM OXODOTREOTIDE LU-177
LUSPATERCEPT-AAMT vs LUTROPIN ALFA